C12N 15/74
Vectors or expression systems specially adapted for prokaryotic hosts other than e.
Official title: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
C12N15/74 (Vectors or expression systems specially adapted for prokaryotic hosts other than e.) appears on 2,993 US grants and 3,849 published applications in this corpus.
Search patents in C12N- Granted patents
- 2,993
- Published applications
- 3,849
- Assignees
- 1,459
- Inventors
- 7,390
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 2 | 0 |
| 1982 | 7 | 0 |
| 1983 | 6 | 0 |
| 1984 | 17 | 0 |
| 1985 | 13 | 0 |
| 1986 | 15 | 0 |
| 1987 | 24 | 0 |
| 1988 | 23 | 0 |
| 1989 | 32 | 0 |
| 1990 | 39 | 0 |
| 1991 | 37 | 0 |
| 1992 | 42 | 0 |
| 1993 | 51 | 0 |
| 1994 | 34 | 0 |
| 1995 | 33 | 0 |
| 1996 | 40 | 0 |
| 1997 | 96 | 0 |
| 1998 | 101 | 0 |
| 1999 | 83 | 0 |
| 2000 | 57 | 0 |
| 2001 | 67 | 8 |
| 2002 | 49 | 63 |
| 2003 | 42 | 318 |
| 2004 | 40 | 55 |
| 2005 | 33 | 72 |
| 2006 | 49 | 66 |
| 2007 | 51 | 57 |
| 2008 | 48 | 49 |
| 2009 | 26 | 63 |
| 2010 | 36 | 76 |
| 2011 | 44 | 107 |
| 2012 | 47 | 89 |
| 2013 | 78 | 126 |
| 2014 | 83 | 148 |
| 2015 | 96 | 126 |
| 2016 | 115 | 158 |
| 2017 | 111 | 153 |
| 2018 | 103 | 180 |
| 2019 | 138 | 240 |
| 2020 | 156 | 234 |
| 2021 | 180 | 221 |
| 2022 | 157 | 250 |
| 2023 | 124 | 249 |
| 2024 | 106 | 276 |
| 2025 | 142 | 267 |
| 2026 | 120 | 198 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tumor-targeting Salmonella gallinarum strain and use thereof6 Oct 2026US 12,751,978 B2Industry Foundation of Chonnam National University
- O-acetyl homoserine-producing microorganism and method for producing o-acetyl homoserine or l-methionine using same6 Oct 2026US 12,753,382 B2Cj Cheiljedang Corporation
- Methods and compositions for producing proteins of interest in pigment deficient bacillus cells22 Sep 2026US 12,741,993 B2Danisco US Inc.
- L-glutamic acid-producing mutant microorganism of genus Corynebacterium, and method for producing l-glutamic acid using same22 Sep 2026US 12,742,159 B2Daesang Corporation
- Heterologous carotenoid production in microorganisms22 Sep 2026US 12,742,193 B2KnipBio, Inc.
- Recombinant expression vector for interferon-beta secretion and attenuated salmonella strain transformed by means of same8 Oct 2026US 2026/0306554 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
- Recombinant expression vector for secreting interleukin-12, and attenuated salmonella strain transformed therewith8 Oct 2026US 2026/0306555 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
- Auxotrophic strains of staphylococcus bacterium8 Oct 2026US 2026/0308565 A1Azitra Inc
- Bacterial type iv secretion systems, methods of use for in vivo dna delivery, and method of engineering8 Oct 2026US 2026/0308604 A1University of Kentucky Research Foundation
- Novel biosynthesis system for producing 3'-phosphoadenosine-5'-phosphosulfate and application thereof8 Oct 2026US 2026/0308651 A1Jiangnan University
Most cited
By later US patents
- CRISPR-Cas component systems, methods and compositions for sequence manipulation560US 8,795,965 B2Massachusetts Institute of Technology · 2014
- CRISPR-Cas component systems, methods and compositions for sequence manipulation529US 8,871,445 B2Massachusetts Institute of Technology · 2014
- Tissue-specific and pathogen-specific toxic agents and ribozymes283US 6,271,359 B1MUSC Foundation for Research Development · 2001
- Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants248US 5,561,236 ABiogen, Inc. · 1996
- Modified enzymes and methods for making same238US 4,760,025 AGenencor, Inc. · 1988